日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tumor-derived SEMA7A regulates fatty acid oxidation in the tumor-associated macrophages to promote the progression of non-small cell lung cancer

肿瘤来源的SEMA7A通过调节肿瘤相关巨噬细胞中的脂肪酸氧化来促进非小细胞肺癌的进展。

Wang, Jia; Shao, Yang; Zhang, Jiameng; Han, Fangfang; Wang, Si; Liu, Beixing

Sema7a drives an immunosuppressive microenvironment of breast cancer via Kdm4a-mediated DNA replication regulation.

Sema7a 通过 Kdm4a 介导的 DNA 复制调控,驱动乳腺癌的免疫抑制微环境。

Bai Xianan, Cai Shanshan, Jiang Jie, Tian Maojin, Du Jianxin, Zhao Peiqing

Correction: SEMA7A-mediated juxtacrine stimulation of IGFBP-3 upregulates IL-17RB at pancreatic cancer invasive front

更正:SEMA7A介导的IGFBP-3旁分泌刺激上调胰腺癌侵袭前沿的IL-17RB。

Chen, Yi-Ing; Tien, Sui-Chih; Ko, Yi-Ling; Chang, Chin-Chun; Hsu, Min-Fen; Chien, Hung Jen; Peng, Hsuan-Yu; Jeng, Yung-Ming; Tien, Yun-Wen; Chang, Yu-Ting; Chang, Ming-Chu; Hu, Chun-Mei

Matrix stiffness induced gallbladder fibroblasts activation and paracrine SEMA7A promotes gallbladder cancer cell epithelial-mesenchymal transition and cancer stem cell-like properties by modulating AKT/p300 signalling.

基质硬度诱导胆囊成纤维细胞活化和旁分泌 SEMA7A 通过调节 AKT/p300 信号传导促进胆囊癌细胞上皮-间质转化和癌症干细胞样特性。

Bimodal genomic approach predicting Semaphorin 7A (SEMA7A) as prognostic biomarker in adrenocortical carcinoma

双峰基因组学方法预测信号素7A (SEMA7A) 作为肾上腺皮质癌的预后生物标志物

Dhall, Anjali; Taniyama, Daiki; Elloumi, Fathi; Luna, Augustin; Varma, Sudhir; Kumar, Suresh; Escobedo, Lauren; Aladjem, Mirit I; Redon, Christophe E; Roper, Nitin; Reinhold, William C; Rivero, Jaydira Del; Pommier, Yves

Author Correction: FUT8-mediated aberrant N-glycosylation of SEMA7A promotes head and neck squamous cell carcinoma progression

作者更正:FUT8介导的SEMA7A异常N-糖基化促进头颈部鳞状细胞癌进展

Liu, Zhonglong; Meng, Xiaoyan; Zhang, Yuxin; Sun, Jingjing; Tang, Xiao; Zhang, Zhiyuan; Liu, Liu; He, Yue

Associations of SEMA7A, SEMA4D, ADAMTS10, and ADAM8 with KRAS, NRAS, BRAF, PIK3CA, and AKT Gene Mutations, Microsatellite Instability Status, and Cytokine Expression in Colorectal Cancer Tissue

SEMA7A、SEMA4D、ADAMTS10 和 ADAM8 与 KRAS、NRAS、BRAF、PIK3CA 和 AKT 基因突变、微卫星不稳定性状态以及细胞因子表达在结直肠癌组织中的关联

Ochman, Błażej; Limanówka, Piotr; Mielcarska, Sylwia; Kula, Agnieszka; Dawidowicz, Miriam; Wagner, Wiktor; Hudy, Dorota; Szrot, Monika; Piecuch, Jerzy Zbigniew; Piecuch, Jerzy; Czuba, Zenon; Świętochowska, Elżbieta

SEMA7A as a Novel Prognostic Biomarker and Its Correlation with Immune Infiltrates in Breast Cancer

SEMA7A作为一种新型预后生物标志物及其与乳腺癌免疫浸润的相关性

Shiyu Zhang,Fanting Kong,Lei Zheng,Xiaowei Li,Lining Jia,Lixian Yang

Pan-Cancer Analysis of the Prognostic and Immunological Role of SEMA7A

SEMA7A的预后和免疫学作用的泛癌分析

Yang, Lixian; Zhang, Shiyu; Zheng, Lei; Kong, Fanting; Dang, Wei; Shen, Shipeng; Li, Xiaowei; Jia, Lining; Zhang, Xiaoru; Lu, Na

A Comprehensive Prognostic Analysis of Tumor-Related Blood Group Antigens in Pan-Cancers Suggests That SEMA7A as a Novel Biomarker in Kidney Renal Clear Cell Carcinoma

一项针对泛癌肿瘤相关血型抗原的综合预后分析表明,SEMA7A可作为肾透明细胞癌的新型生物标志物

Wang, Yange; Li, Chenyang; Qi, Xinlei; Yao, Yafei; Zhang, Lu; Zhang, Guosen; Xie, Longxiang; Wang, Qiang; Zhu, Wan; Guo, Xiangqian